Melissa Stewart
Family · Atlanta, GANPI 1376904623
Payments from drug & device makers
Across 195 payments — averaging $22.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bristol Myers Squibb$952
- Incyte Corporation$330
- Astellas Pharma US Inc$292
- Paratek Pharmaceuticals, Inc.$191
- Janssen Scientific Affairs, LLC$179
- Takeda Pharmaceuticals U.S.A., Inc.$176
- plus $2K from 35 others
What the payments were for
- Food & beverage$4,329100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bristol Myers Squibb | 45 | $952 |
| Incyte Corporation | 16 | $330 |
| Astellas Pharma US Inc | 12 | $292 |
| Paratek Pharmaceuticals, Inc. | 6 | $191 |
| Janssen Scientific Affairs, LLC | 7 | $179 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $176 |
| Karyopharm Therapeutics Inc. | 9 | $166 |
| AbbVie | 7 | $160 |
| Johnson & Johnson | 7 | $146 |
| E.r. Squibb & Sons, L.L.C. | 1 | $126 |
| Pharmacyclics LLC, An Abbvie Company | 5 | $125 |
| ADC Therapeutics America, Inc. | 6 | $113 |
| Jazz Pharmaceuticals Inc. | 6 | $111 |
| Pfizer | 5 | $93 |
| Legend Biotech USA Inc. | 4 | $88 |
| GSK | 4 | $88 |
| Sanofi-aventis U.S. LLC | 4 | $83 |
| Sobi, Inc | 4 | $70 |
| AstraZeneca | 3 | $66 |
| Morphosys, US Inc. | 4 | $64 |
| Seagen Inc. | 3 | $57 |
| Gilead | 2 | $56 |
| Boston Scientific | 1 | $55 |
| Servier Pharmaceuticals LLC | 3 | $52 |
| Sanofi | 2 | $43 |
| Daiichi Sankyo Inc. | 2 | $42 |
| Blueprint Medicines Corporation | 2 | $41 |
| Amgen | 2 | $39 |
| Genentech USA, Inc. | 2 | $39 |
| Stemline Therapeutics Inc. | 2 | $35 |
| Acrotech Biopharma Inc. | 2 | $34 |
| Novartis | 1 | $31 |
| Merck | 1 | $31 |
| Coherus Oncology, Inc. | 1 | $25 |
| Syndax Pharmaceuticals, Inc. | 1 | $23 |
| Rigel Pharmaceuticals, Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $22 |
| Octapharma USA, Inc. | 1 | $18 |
| Melinta Therapeutics, LLC | 1 | $16 |
| Beigene USA, Inc. | 1 | $16 |
| Genmab U.S., Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,329 in reported general payments places this provider in the 90th percentile of 6,258 family providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Acyclovir | 40 | $713 |
| Penicillin V Potassium | 13 | $261 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 20 | $50 |
Paid to pharmacies, not to this prescriber.
Other family in Atlanta
- Stacey TatroeAtlanta$38K
- Brandy HughesAtlanta$29K
- Cecile MartinAtlanta$23K
- Terri CowanAtlanta$21K
- Brandi Pinckney-GreeneAtlanta$18K
- Michelle SarievAtlanta$18K
- Christopher VreelandAtlanta$17K
- Angelica MillerAtlanta$15K
- Andrea Jefferson SaboorAtlanta$14K
- Allie McAllisterMarietta$299K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.